Particularly, in hepatic fibrosis, GE exerted significant protective effects by preventing TGF-β-induced epithelial–mesenchymal transition (EMT) via inhibition of the TGFβ/Smad and ERK signaling pathways (Park et al., 2015). This evidence concerns the gene TGFB1 and Hepatic fibrosis.